Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-03-10 10:42 am Sale | 13G | Merus N.V. MRUS | FEDERATED HERMES INC. FHI | 2,138,700 4.62% | -1,785,595 (-45.50%) | View |
| 2023-02-14 4:05 pm Purchase | 13G | Merus N.V. MRUS | COMMODORE CAPITAL LP | 2,732,567 5.9% | 490,343 (+21.87%) | View |
| 2023-02-14 4:00 pm Sale | 13G | Merus N.V. MRUS | BAKER BROS. ADVISORS LP | 0 0% | -2,037,469 (Position Closed) | View |
| 2023-02-14 12:03 pm Sale | 13G | Merus N.V. MRUS | BIOTECHNOLOGY VALUE FUND L P | 2,978,420 6.4% | -1,156,651 (-27.97%) | View |
| 2023-02-10 09:36 am Sale | 13G | Merus N.V. MRUS | Flynn James E | 2,380,438 5.14% | -141,115 (-5.60%) | View |
| 2023-02-06 2:43 pm Purchase | 13G | Merus N.V. MRUS | WELLINGTON MANAGEMENT GROUP LLP | 3,690,352 7.97% | 535,801 (+16.99%) | View |
| 2023-02-01 11:06 am Purchase | 13G | Merus N.V. MRUS | FEDERATED HERMES INC. FHI | 3,924,295 8.48% | 244,995 (+6.66%) | View |
| 2022-09-30 3:29 pm Purchase | 13G | Merus N.V. MRUS | Flynn James E | 2,521,553 5.5% | 2,521,553 (New Position) | View |
| 2022-05-16 4:30 pm Purchase | 13G | Merus N.V. MRUS | COMMODORE CAPITAL LP | 2,242,224 5.1% | 2,242,224 (New Position) | View |
| 2022-02-14 4:10 pm Purchase | 13G | Merus N.V. MRUS | Boxer Capital LLC | 1,900,000 4.4% | 300,000 (+18.75%) | View |
| 2022-02-14 1:09 pm Purchase | 13G | Merus N.V. MRUS | FEDERATED HERMES INC. FHI | 3,679,300 8.51% | 742,502 (+25.28%) | View |
| 2022-02-11 7:22 pm Sale | 13G | Merus N.V. MRUS | BIOTECHNOLOGY VALUE FUND L P | 4,135,071 9.6% | -925,000 (-18.28%) | View |
| 2022-02-04 09:12 am Sale | 13G | Merus N.V. MRUS | WELLINGTON MANAGEMENT GROUP LLP | 3,154,551 7.39% | -1,445,807 (-31.43%) | View |
| 2021-08-10 07:57 am Purchase | 13G | Merus N.V. MRUS | WELLINGTON MANAGEMENT GROUP LLP | 4,600,358 12% | 3,470,723 (+307.24%) | View |
| 2021-07-07 4:35 pm Sale | 13G | Merus N.V. MRUS | BIOTECHNOLOGY VALUE FUND L P | 5,060,071 13.2% | -745,500 (-12.84%) | View |
| 2021-02-12 4:16 pm Purchase | 13G | Merus N.V. MRUS | BIOTECHNOLOGY VALUE FUND L P | 5,805,571 19.96% | 815,000 (+16.33%) | View |
| 2021-02-12 3:52 pm Sale | 13G | Merus N.V. MRUS | EcoR1 Capital LLC | 0 0% | -1,906,861 (Position Closed) | View |
| 2021-02-12 12:46 pm Unchanged | 13G | Merus N.V. MRUS | FEDERATED HERMES INC. FHI | 2,936,798 10.1% | 0 (Unchanged) | View |
| 2021-02-11 08:41 am Unchanged | 13G | Merus N.V. MRUS | Medicxi Growth I LP | 1,600,000 4.3% | 0 (Unchanged) | View |
| 2021-01-25 4:08 pm Purchase | 13D | Merus N.V. MRUS | INCYTE CORP INCY | 3,550,000 9.4% | 350,000 (+10.94%) | View |